Cargando…
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Hypothalamic neuropeptides named hypocretin/orexins which were identified in 1998 regulate critical functions such as wakefulness in the central nervous system. These past 20 years had revealed that orexins/receptors system was also present in the peripheral nervous system where they participated to...
Autores principales: | Couvineau, Alain, Voisin, Thierry, Nicole, Pascal, Gratio, Valerie, Blais, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641057/ https://www.ncbi.nlm.nih.gov/pubmed/34908800 http://dx.doi.org/10.3748/wjg.v27.i44.7582 |
Ejemplares similares
-
The Orexin receptors: Structural and anti-tumoral properties
por: Couvineau, Alain, et al.
Publicado: (2022) -
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
por: Alain, Couvineau, et al.
Publicado: (2021) -
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
por: Couvineau, Alain, et al.
Publicado: (2019) -
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
por: Couvineau, Alain, et al.
Publicado: (2018) -
The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment
por: Voisin, Thierry, et al.
Publicado: (2022)